Hematological Malignancy Patients, COVID-19, and Favipiravir

被引：0
|
作者：
Mungmunpuntipantip, Rujittika [1 ]
Wiwanitkit, Viroj [1 ]
机构：
[1] DY Patil Univ, Pune, Maharashtra, India
来源：
TURKISH JOURNAL OF HEMATOLOGY | 2021年 / 38卷 / 04期
关键词：
Malignancy; COVID-19; Favipirav;
D O I：
10.4274/tjh.galenos.2021.2021.0582
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [21] Role of favipiravir in the treatment of COVID-19
    Joshi, Shashank
    Parkar, Jalil
    Ansari, Abdul
    Vora, Agam
    Talwar, Deepak
    Tiwaskar, Mangesh
    Patil, Saiprasad
    Barkate, Hanmant
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 102 : 501 - 508
  • [22] Comment on: Favipiravir, an antiviral for COVID-19?
    Chachaima-Mar, Jorge
    Perez-Castilla, Jesus
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (01) : 279 - 280
  • [23] Favipiravir for COVID-19 in a Patient on Hemodialysis
    Hirai, Daisuke
    Yamashita, Daisuke
    Seta, Koichi
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (01) : 153 - 154
  • [24] Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients
    Yevgi, Recep
    Bilge, Nuray
    Simsek, Fatma
    EURASIAN JOURNAL OF MEDICINE, 2021, 53 (02): : 164 - 165
  • [25] EFFECTIVENESS AND SAFETY OF FAVIPIRAVIR INFUSION IN PATIENTS HOSPITALIZED WITH COVID-19
    Balykova, L. A.
    Zaslavskaya, K. Ya.
    Pavelkina, V. F.
    Pyataev, N. A.
    Selezneva, N. M.
    Kirichenko, N. V.
    Ivanova, A. Yu.
    Rodoman, G. V.
    Kolontarev, K. B.
    Skrupsky, K. S.
    Simakina, E. N.
    Mubarakshina, O. A.
    Taganov, A. V.
    Pushkar, D. Yu.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2022, 10 (01): : 113 - 126
  • [26] Favipiravir and COVID-19: A Simplified Summary
    Ghasemnejad-Berenji, Morteza
    Pashapour, Sarvin
    DRUG RESEARCH, 2021, 71 (03) : 166 - 170
  • [27] Favipiravir Use in COVID-19 Treatment
    Kara, Emre
    Inkaya, Ahmet Cagkan
    Demirkan, Kutay
    Unal, Serhat
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (01): : 1 - 11
  • [28] Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy
    Seki, Masafumi
    Hashimoto, Kosuke
    Kondo, Nami
    Ohya, Yoshitaka
    Kotajima, Futoshi
    Mitsutake, Kotaro
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 7117 - 7124
  • [29] Effectiveness of Early Favipiravir Therapy in Hospitalised COVID-19 Patients
    Tawfik, Abdulrahman
    Alzahrani, Abdulrahman
    Alharbi, Sami
    Almitairi, Jamal
    Alzahrani, Arwa
    Alshehri, Mohammed Ali
    Aldughaim, Mohammed S.
    Alothaid, Hani
    ADVANCES IN VIROLOGY, 2022, 2022
  • [30] Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients
    Chen, Ping-Jen
    Chao, Chien-Ming
    Lai, Chih-Cheng
    JOURNAL OF INFECTION, 2021, 82 (05) : 199 - 200
12345